Live Breaking News & Updates on Corad

Stay informed with the latest breaking news from Corad on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Corad and stay connected to the pulse of your community

CBS Weekend News

morant has not cod. t corad pitcher ryan feltner is in the hospital with a skull fracture after a very scary play. this video is tough to watch. a phillies batter hit a line drive that hit feltner. he drops to the ground. remarkably, he never appeared to lose consciousness. he walked off the field with help from his teammates. tonight we finally know who won the world's biggest song competition. >> 243 points, we have a winner! sweden, you have -- >> swedish singer loreen is the euro vision singer beating some extravagant acts from 25 other countries. loreen is the second performer to take home the top prize twice. she won back in 2012. this year's event was held in liverpool, england. next on the "cbs weekend news," these two pilots just soared into aviation history. we'll tell you how. stay with us.

Play , Hit-feltner , Video , Ryan-feltner , Hospital , Skull-fracture , Batter-hit-a-line-drive , Corad , Help , World , Teammates , Song

Scorad Medical distributes Texray radiation protection devices in the Netherlands

Announcement | Texray AB Gothenburg, Sweden from October 18th, 2021 | Scorad Medical BV and Texray AB signed a distribution agreement effective for the...

Sweden , Netherlands , Gothenburg , Vastra-gotalands-lan , Petra-apell , Texray-radiation , Rik-pierlo , Teamleader-radiology , Holdingbolaget-vid-göteborgs-universitet , U-ventures , Etra-apell

LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021

LEO Pharma
LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021
Monday, April 26, 2021 1:00PM IST (7:30AM GMT)

Ballerup, Denmark & Madison, N.J., United States:

Interim analysis at 56 weeks from ECZTEND, an open-label extension trial, demonstrates sustainable and durable efficacy of tralokinumab in adult patients
1
Patients enrolled in ECZTRA 1 and 2 parent trials who continued into ECZTEND have now been treated with tralokinumab for two years
1
1

LEO Pharma A/S, a global leader in medical dermatology, today announced results on the long-term safety and efficacy profile of tralokinumab in adult patients with moderate-to-severe atopic dermatitis. Results were shared as an oral presentation during the American Academy of Dermatology Virtual Meeting Experience (AAD VMX) 2021.

Oregon , United-states , Japan , Portland , Denmark , Ballerup , Hovedstaden , Japanese , American , Linda-mayer , Andrew-blauvelt , Oregon-medical-research-center